Brigatinib from Canada
Brigatinib is an ALK inhibitor for lung cancer treatment. This macrocyclic aromatic nitrogen-heterocycle drug substance imports under HTS 2933.99.75.00.
Duty Rate — Canada → United States
16.5%
Rate breakdown
9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada
Import Tips
• GMP compliance audit trail required from API manufacturer
• Residual solvent analysis per ICH Q3C mandatory for entry
• Avoid declaring as 'new chemical entity' after FDA approval